<unk>  is an antidiabetic agent that is FDA approved for the {{{indicationType}}} of type 2 diabetes mellitus.   Common adverse reactions include hypoglycemia, diarrhea, arthralgia, headache, sinusitis, and upper respiratory infection.
Repaglinide
Liraglutide
Linagliptin
Mitiglinide
Exenatide
Vildagliptin
Glyburide
Insulin glulisine